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Background In pediatric cardiac surgery, anticoagulation proto-
cols are derived from adult protocols. Age, Antithrombin III level,
and capacity to generate thrombin are factors that affect unfrac-
tionated heparin (UFH) action in children. A starting UFH dose of
400UI/kg is recommended to get an Activated Clotting Time (ACT)
target over 400 seconds. In our daily practice, we noticed a wide
range of ACT increase (ACT) after this standardized weight based
bolus of UFH.
Objective To deﬁne factors affecting UFH effectiveness based on
ACT before CPB initialization in pediatric cardiac surgery.
Methods A retrospective chart review of patient undergoing
cardiac surgery requiring CPB in a single university hospital was per-
formed. Patients receiving preoperative anticoagulation therapy or
platelet aggregation inhibitors were excluded. We searched predic-
tive factors for ACT. We deﬁned 2 groups: hyperrespondents (HR;
ACT> 500) and normorespondents (NR; ACT< 500).
Results Seventy-nine charts were reviewed. Median [25—75] age
and weight were respectively 13.8 [5—72] months and 8.7 kg
[5.5—18.8]. UFH pre CPB bolus was 384 [358—410] to increase
pre operative ACT from 124 [115—137] to 536 s[463—582]. HR are
younger (4.9 [3.7—13] vs 24.6 [5.7—76] months, P < 0.05) and have
smaller weight (6,1 [4.6—7.8] vs 10 kg[5,8—19.5], P < 0,05) than NR.
ACT is correlated to UFH dose for patients > 5 months (r = 0.59
P = 0.00001) and > 5 kg (r = 0.54 P = 0.00001) for with a predictive
ACT of 386 s [325—443]. There is no correlation between ACT
and UFH dose for patients < 5 months and < 5 kg.
Conclusion A dose UFH of 400UI/kg before starting CPB in pedi-
atrics is overestimated, especially for children < 5 months and < 5 kg.
Accurate dose for ACT target > 400 s in this speciﬁc population
should be calculated using other method that still needs to be
developed to avoid complications associated to excessive dose of
UFH.
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Introduction NTproBNP assessment remains limited in congen-
ital cardiology, particularly in patients with univentricular heart
physiology who underwent total cavopulmonary connection (TCPC)
where long-term prognosis is greatly related to ventricular function.
Aim To evaluate the NTproBNP after TCPC and seek a correlation
with clinical and laboratory monitoring.
Methods A retrospective study was initiated on all TCPC patients
born after 1991. Demographic, anatomical, echocradiography data
and NTproBNP serum level were collected following the early
post-operative period. Routine NTproBNP screening for these
patients was initiated in our institution in 2008. NTproBNP Z-
score was calculated based on our published equation from healthy
children.
Results Of a total of 46 patients who completed TCPC, 5
died post-operatively. All remaining 41 subjects had available
NTproBNP beyond the immediate post-operative period and con-
stituted the study population. NTproBNP was signiﬁcantly elevated
during the ﬁrst post-operative year (Z-score 1.9± 1.17) compared
to mid-term follow-up (3—5 years) (Z-score 1.23± 0.72), P = 0.03.
Mean NTproBNP Z-score increased in the subsequent years to
1.6± 1.1 (P = 0.21 vs year-1 post TCPC, and 0.06 vs mid-term). Z-
scores > 2.0 were associated with a lower serum albumin (39.2± 3.3
vs 44.4± 4.4mg/dL; P = 0.04), but not with other laboratory tests.
There were however no identiﬁable predisposing clinical factors
(i.e., ventricular morphology, age), preoperative hemodynamic
data (PVRi, mean pulmonary artery pressure, Nakata index), sur-
gical speciﬁcs (type of TCPC, presence of fenestration, pacemaker
implantation), or postoperative events.
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